Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Guido Palamara"'
Autor:
Valentina Svicher, Valeria Cento, Gabriella Rozera, Isabella Abbate, Maria Mercedes Santoro, Daniele Armenia, Lavinia Fabeni, Alessandro Bruselles, Alessandra Latini, Guido Palamara, Valeria Micheli, Giuliano Rizzardini, Caterina Gori, Federica Forbici, Giuseppe Ippolito, Massimo Andreoni, Andrea Antinori, Francesca Ceccherini-Silberstein, Maria Rosaria Capobianchi, Carlo Federico Perno
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e53603 (2013)
ObjectiveThe false-positive rate (FPR) is a percentage-score provided by Geno2Pheno-algorithm indicating the likelihood that a V3-sequence is falsely predicted as CXCR4-using. We evaluated the correlation between FPR obtained by V3 population-sequenc
Externí odkaz:
https://doaj.org/article/7be4060c35a74e85964f9b67de9f8f00
Autor:
Massimo Giuliani, Lorenzo Nosotti, Alessandra Latini, Concetta Mirisola, Fulvia Pimpinelli, Sabrina Volpi, Fabrizio Ensoli, Gianpaolo Impara, Guido Palamara
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 3, Iss 1, Pp e2011058-e2011058 (2011)
In the Mediterranean countries, hepatitis C virus infection affect nearly 45% of HIV-1 infected individuals, consistently to the high proportion of patients with a history of intravenous drug use and exposed to the two viruses by parenteral route. Ev
Externí odkaz:
https://doaj.org/article/c2e3951c035140e180829f8a26cc33f9
Autor:
Fabrizio Ensoli, Sabrina Volpi, Fulvia Pimpinelli, Concetta Mirisola, Alessandra Latini, Lorenzo Nosotti, Massimo Giuliani, Gianpaolo Impara, Guido Palamara
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 3, Iss 1, Pp e2011058-e2011058 (2011)
In the Mediterranean countries, hepatitis C virus infection affect nearly 45% of HIV-1 infected individuals, consistently to the high proportion of patients with a history of intravenous drug use and exposed to the two viruses by parenteral route. Ev
Externí odkaz:
https://doaj.org/article/77bf6e30610e466baddf7cd4267b690d
Autor:
Barbara Ensoli, Stefania Bellino, Antonella Tripiciano, Olimpia Longo, Vittorio Francavilla, Simone Marcotullio, Aurelio Cafaro, Orietta Picconi, Giovanni Paniccia, Arianna Scoglio, Angela Arancio, Cristina Ariola, Maria J Ruiz Alvarez, Massimo Campagna, Donato Scaramuzzi, Cristina Iori, Roberto Esposito, Cristina Mussini, Florio Ghinelli, Laura Sighinolfi, Guido Palamara, Alessandra Latini, Gioacchino Angarano, Nicoletta Ladisa, Fabrizio Soscia, Vito S Mercurio, Adriano Lazzarin, Giuseppe Tambussi, Raffaele Visintini, Francesco Mazzotta, Massimo Di Pietro, Massimo Galli, Stefano Rusconi, Giampiero Carosi, Carlo Torti, Giovanni Di Perri, Stefano Bonora, Fabrizio Ensoli, Enrico Garaci
Publikováno v:
PLoS ONE, Vol 5, Iss 11, p e13540 (2010)
UnlabelledAlthough HAART suppresses HIV replication, it is often unable to restore immune homeostasis. Consequently, non-AIDS-defining diseases are increasingly seen in treated individuals. This is attributed to persistent virus expression in reservo
Externí odkaz:
https://doaj.org/article/6ed34be1303c4aca8283aa4593dab48a
Autor:
Guido Palamara, Alessandra Latini, Evangelo Boumis, Carlo Federico Perno, Chiara Tommasi, Federica Forbici, Claudia Alteri, Francesca Ceccherini-Silberstein, Rita Bellagamba, Caterina Gori, Maria Mercedes Santoro, Andrea Antinori, Pasquale Narciso, Daniele Armenia, Raffaella Libertone, Carmela Pinnetti, Vanni Borghi, Mario Santoro, Emanuele Nicastri, Cristina Mussini, Lavinia Fabeni, Adriana Ammassari, Valerio Tozzi, Andrea Calcagno, Valentina Svicher, Massimo Andreoni, Giovanni Di Perri, Philippe Flandre, A. R. Buonomini
Publikováno v:
Antiviral Therapy; Vol 18
Background We tested whether pre-HAART viraemia affects the achievement and maintenance of virological success in HIV-1-infected patients starting modern first-line therapies. Methods A total of 1,430 patients starting their first HAART (genotype-tai
Autor:
Guido Palamara, Fulvia Pimpinelli, Alessandra Latini, Domenico Moretto, Amina Vocaturo, Giampaolo Impara, Aldo Di Carlo, Maria Benevolo, Amalia Giglio, Maria Gabriella Donà, Massimo Giuliani
Publikováno v:
Journal of Clinical Virology. 54:185-189
Background Anal human papillomavirus (HPV) infection is very common in men having sex with men (MSM), but the available data on its burden and characteristics mainly concern HIV-infected individuals. Objectives This study aimed to assess the prevalen
Autor:
A. Di Carlo, Elisabetta Trento, Fabrizio Ensoli, C. Ferraro, Antonio Bonadies, S. Bultrini, Carlo Cota, S. Bucher, Marco Ardigò, B. Amorosi, Paola Cordiali-Fei, Massimo Giuliani, F. M. Solivetti, Guido Palamara, Alessandra Latini
Publikováno v:
Dermatologic Therapy. 25:214-218
The present prospective study was aimed at evaluating the long-term efficacy of local electrochemotherapy (ECT) with the intravenous administration of bleomycin, on disease progression and viral activity in classic Kaposi's sarcoma (cKS), a vascular
Autor:
Guido Palamara, Alessandra Latini, Giuseppe Tambussi, Paolo Monini, Adriano Lazzarin, Barbara Ensoli, Gianpiero D'Offizi, Maria Josè Ruiz Alvarez, Enrico Garaci, Barbara Collacchi, Massimo Giuliani, Arianna Scoglio, Aldo Di Carlo, Chiara Tassan Din, Marina Giulianelli, Maria Carta, Andrea Antinori, Pasquale Narciso, Stefania Bellino, Antonella Tripiciano, Olimpia Longo, Mauro Magnani, Fabrizio Ensoli, Valeria Fiorelli, Vittorio Francavilla, Angela Arancio, Giovanni Paniccia, Raffaele Visintini
Publikováno v:
Vaccine. 28:371-378
The native HIV-1 Tat protein was chosen as vaccine candidate for phase I clinical trials based on its role in the natural infection and AIDS pathogenesis, on the association of Tat-specific immune response with the asymptomatic stage as well as on it
Autor:
Vittorio Francavilla, Olimpia Longo, Adriano Lazzarin, A. Di Carlo, Mauro Magnani, Antonella Tripiciano, Guido Palamara, Fabrizio Ensoli, Angela Arancio, Giuseppe Tambussi, Marinella Giulianelli, Gianpiero D’Offizi, Paolo Monini, C. Tassan Din, Arianna Scoglio, Maria Carta, Giovanni Paniccia, Raffaele Visintini, Pasquale Narciso, Maria Elena Laguardia, Massimo Giuliani, Stefania Bellino, Andrea Antinori, Massimo Campagna, Barbara Ensoli, Valeria Fiorelli, Barbara Collacchi
Publikováno v:
ResearcherID
The native HIV-1 Tat protein was chosen as vaccine candidate for phase I clinical trials in both uninfected (ClinicalTrials.gov identifier: NCT00529698) and infected volunteers (ClinicalTrials.gov identifier: NCT00505401). The rationale was based on
Autor:
Guido Palamara, Alessandra Latini, Massimo Ciccozzi, Massimo Giuliani, Maria Mercedes Santoro, Carlo Federico Perno, G. Rezza, Claudia Alteri, Stefania Montieri
Publikováno v:
AIDS Research and Human Retroviruses. 25:157-164
An increase in the circulation of HIV-1 non-B subtypes has been observed in recent years in Western European countries. Due to the lack of data on the circulation of HIV-1 non-B subtypes among European HIV-1-infected men who have sex with men (MSM),